ImmunoGen
$3.129876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.19 (-5.89%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ImmunoGen and other stocks, options, ETFs, and crypto commission-free!
About IMGN
ImmunoGen, Inc. Common Stock, also called ImmunoGen, is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Read More Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.
Employees
296
Headquarters
Waltham, Massachusetts
Founded
1981
Market Cap
496.12M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.52M
High Today
$3.30
Low Today
$3.10
Open Price
$3.30
Volume
1.63M
52 Week High
$9.84
52 Week Low
$1.76
Collections
Price Paid on Robinhood
28% Lower
Right Now
52 Week Low
$2.27
Average Price Paid
$4.36
52 Week High
$12.31
Analyst Ratings
50%
of 10 ratings
Buy
50%
Hold
40%
Sell
10%
IMGN Earnings
-$0.33
-$0.25
-$0.18
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 1, Pre-Market